HomeHealthcare & Life SciencesPharmaceuticals Myasthenia Gravis Treatment Market

Benelux Myasthenia Gravis Treatment Market Size & Outlook, 2025-2033


Benelux Myasthenia Gravis Treatment Market Insights

  • As per Reed Intelligence insights, the Benelux Myasthenia Gravis Treatment Market stood at USD 40.22 Million in 2024 and is anticipated to grow to USD 97.47 Million by 2033.
  • The Benelux market is expected to advance at a CAGR of 10.36% from 2026 through 2033.
  • In 2024, Ocular MG  accounted for the highest share of the By Type market size.
  • During the forecast period, Transient Neonatal MG is set to register the highest growth, making it the most lucrative By Type segment.

Other Key Findings


  • In 2024, Benelux represented 1.91% of the overall global Myasthenia Gravis Treatment Market size.
  • United States is projected to lead the global Myasthenia Gravis Treatment Market size by 2033.
  • Across Europe, Germany is anticipated to hold the dominant position in market size by 2033.
  • Benelux is forecasted to expand at the fastest pace in Europe, attaining USD 97.67 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 40.22 Million
Market Size In 2033 USD 97.47 Million
Largest segment Ocular MG 
Units Revenue in USD Million
CAGR 10.36% (2025-2033)
Segmnetation Covered
By Type
  1. Ocular MG 
  2. Congenital MG 
  3. Transient Neonatal MG
By Treatment
  1. Medication 
  2. Surgery 
  3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
  4. Plasmapheresis and Intravenous Immunoglobulin 
  5. Others
By End-User
  1. Hospitals 
  2. Clinics 
  3. Academic Research Institutes 
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports